BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• 

  Business

  Four New Biotechs to Watch: Esker, Mogrify, Isolere and BridGene

  There’s money on the move and venture capital firms launch several biotech companies with hefty Series A financing rounds. Here’s a look.

  May 5, 2021

   · 

  4 min read

   · 

  Mark Terry
• 

  Business

  Money on the Move: April 29 – May 4

  April showers bring May dollars. Here’s whose cash gardens are really blooming this week in the life sciences world.

  May 5, 2021

   · 

  5 min read

   · 

  Kate Goodwin
• 

  Deals

  Amryt and Chiasma Combine to Form Rare and Orphan Diseases Powerhouse

  Amryt inked an all-stock acquisition deal with Chiasma. The combined company will focus on rare and orphan diseases with three marketed products and a strong development pipeline.

  May 5, 2021

   · 

  3 min read

   · 

  Mark Terry
• 

  Drug Development

  Clinical News: MDMA and Therapy Significantly Benefits PTSD Patients and More

  BioSpace takes a look at data released this week from some of the numerous ongoing clinical studies to advance potential therapies and treatment for disease. Here are some of them.

  May 5, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  FDA Cites Concerns Over ChemoCentryx’s Avacopan Trial Data, Sending Stock off a Cliff

  The U.S. FDA cites concerns regarding clinical data for ChemoCentryx’s investigational rare autoimmune disease therapy avacopan. Shares in the company plunged 46.5% lower following the release of the document.

  May 5, 2021

   · 

  3 min read

   · 

  Brandon May
• 

  Career Advice

  How To Build A Resume During the Pandemic

  Learn some essential tips on how to build a resume or how to enhance your resume during COVID-19. These tips can increase the chances of getting you to the interview stage.

  May 5, 2021

   · 

  2 min read

   · 

  Brandi Marcene
• 

  Drug Development

  COVID-19 May Increase Risk of Diabetes, New Study Claims

  Patients without diabetes who develop COVID-19 may be at a higher risk of actually developing diabetes following recovery, recent study claims.

  May 5, 2021

   · 

  2 min read

   · 

  Brandon May
• 

  What You Need to Know to Become a Medical Scribe

  There is a growing demand for medical scribes, and for good reason. Read on to discover how and why to become a medical scribe in our complete guide.

  May 5, 2021

   · 

  4 min read

   · 

  Lorenzo Soliman
• 

  Business

  Merck Veteran Roger Perlmutter Emerges From Stealth Mode With Eikon Therapeutics

  Roger Perlmutter, the former president of Merck Research Laboratories, will helm drug discovery startup Eikon Therapeutics, Inc.

  May 5, 2021

   · 

  3 min read

   · 

  Alex Keown
• 

  Drug Development

  Pfizer-BioNTech Vaccine Raking In Revenue; Novavax on Its Heels With Adolescent Trials

  Here’s a look at Pfizer-BioNTech, Novavax and the COVID-19 vaccine’s sales, approval in children, additional trials, potential of booster shots, and more.

  May 5, 2021

   · 

  5 min read

   · 

  Mark Terry